Association of GSTT1/GSTM1 and ApoE variants with left ventricular diastolic dysfunction in thalassaemia major patients

References

• Gammella E, Recalcati S, Rybinska I, et al. Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms. Oxid Med Cell Longev. 2015;2015: Article ID: 230182. http://dx.doi.org/10.1155/2015/230182
   PubMed Web of Science ®Google Scholar
• Lekawanvijit S, Chattipakorn N. Iron overload thalassemic cardiomyopathy: ironstatus assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity. Can J Cardiol. 2009;25(4):213–8. doi: 10.1016/S0828-282X(09)70064-9
   PubMed Web of Science ®Google Scholar
• Kremastinos DT, Farmakis D, Aessopos A, et al. Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail. 2010;3:451–8. doi: 10.1161/CIRCHEARTFAILURE.109.913863
   PubMed Web of Science ®Google Scholar
• Walter PB, Fung EB, Killilea DW, et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol. 2006;135:254–263. doi: 10.1111/j.1365-2141.2006.06277.x
   PubMed Web of Science ®Google Scholar
• Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61(3):154–166. doi: 10.1159/000028396
   PubMed Web of Science ®Google Scholar
• Ginsberg G, Smolenski S, Hattis D, et al. Genetic polymorphism in glutathione transferases (GST): population distribution of GSTM1, T1, and P1 conjugating activity. J Toxicol Environ Health B Crit Rev. 2009;12(5-6):389–439. doi: 10.1080/10937400903158375
   PubMed Web of Science ®Google Scholar
• Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet. 1996;14:55–61. doi: 10.1038/ng0996-55
   PubMed Web of Science ®Google Scholar
• El-Tagui MH, Hamdy MM, Shaheen IA, et al. Apolipoprotein E gene polymorphism and the risk of left ventricular dysfunction among Egyptian β thalassemia major. Gene. 2013;524(2):292–5. doi: 10.1016/j.gene.2013.03.134
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(04):277–314. doi: 10.1016/j.echo.2016.01.011
   PubMed Web of Science ®Google Scholar
• Khoury PR, Mitsnefes M, Daniels SR, et al. Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr. 2009;22:709–714. doi: 10.1016/j.echo.2009.03.003
   PubMed Web of Science ®Google Scholar
• Hixson JE, Cox LA, Borenstein S. The APOE polymorphism world distribution 309 baboon apolipoprotein E gene: structure, expression, and linkage with the gene for apolipoprotein C-1. Genomics. 1988;2:315–323. doi: 10.1016/0888-7543(88)90020-1
   PubMed Web of Science ®Google Scholar
• Sclafani S, Calvaruso G, Agrigento V, et al. Glutathione S transferase polymorphisms influence on iron overload in β-thalassemia patients. Thalassemia Reports. 2013;3(e6):20–22.
   Google Scholar
• Brissot P, Ropert M, Le Lan C et al. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta. 2012;1820(3):403-10 doi: 10.1016/j.bbagen.2011.07.014
   PubMed Web of Science ®Google Scholar
• Rose RA, Sellan M, Simpson JA, et al. Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(5):733–42. doi: 10.1161/CIRCEP.110.960401
   PubMed Web of Science ®Google Scholar
• Cheng CF, Lian WS. Prooxidant mechanisms in iron overload cardiomyopathy. Biomed Res Int. 2013;2013:Article ID: 740573. http://dx.doi.org/10.1155/2013/740573
   Web of Science ®Google Scholar
• Kautz L, Nemeth E. Molecular liaisons between erythropoiesis and iron metabolism. Blood. 2014;124(4):479–82. doi: 10.1182/blood-2014-05-516252
   PubMed Web of Science ®Google Scholar
• Atiq M, Bana M, Ahmed US, et al. Cardiac disease in beta-thalassemia major: is it reversible? Singapore Med J. 2006;47:693–6.
   PubMedGoogle Scholar
• Karamanou AG, Hamodraka ES, Vrakas SC, et al. Assessment of left ventricular and atrial diastolic function using two-dimensional (2D) strain imaging in patients with β-thalassemia major. Eur J Haematol. 2014;92(1):59–65. doi: 10.1111/ejh.12209
   PubMed Web of Science ®Google Scholar
• Aessopos A, Berdoukas V. Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management. Mediterr J Hematol Infect Dis. 2009;1(1):e2009002.
   PubMedGoogle Scholar
• Mitter SS, Shah SJ, Thomas JD. A test in context: E/A and E/e’ to assess diastolic dysfunction and LV filling pressure. J Am Coll Cardiol. 2017;69(11):1451–1464. doi: 10.1016/j.jacc.2016.12.037
   PubMed Web of Science ®Google Scholar
• Chakarov I, Vlaykova T, Slavov E, et al. Role of serum pro-hepcidin and GSTM1 and GSTT1 null polymorphisms for estimation of the risk of myocardial siderosis in children and “young adults” with β-thalassemia major. Comp Clin Pathol. 2014;23:725–733. doi: 10.1007/s00580-013-1677-9
   Google Scholar
• Abo-Shanab AM, El-Desouky MA, Kholoussi NM, et al. The relation between glutathione S-transferase M1 null-genotype and cardiacproblems in beta-thalassemia. Acta Biochim Pol. 2016;63(2):267–71. doi: 10.18388/abp.2015_1076
   PubMed Web of Science ®Google Scholar
• Wu KH, Chang JG, Ho YJ, et al. Glutathione S transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with beta-thalassemia major. Hemoglobin. 2006;30(2):251–6. doi: 10.1080/03630260600642575
   PubMed Web of Science ®Google Scholar
• Meral A, Tuncel P, Surmen-Gur E, et al. Lipid peroxidation and antioxidant status in beta-thalassemia. Pediatr Hematol Oncol. 2000;17(8):687–693. doi: 10.1080/08880010050211402
   PubMed Web of Science ®Google Scholar
• Tsimikas S, Miller YI. Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr Pharm Des. 2011;17(1):27–37. doi: 10.2174/138161211795049831
   PubMed Web of Science ®Google Scholar
• Dimou NL, Pantavou KG, Bagos PG. Apolipoprotein E polymorphism and left ventricular failure in beta-thalassemia: a multivariate meta-analysis. Ann Hum Genet. 2017;81(5):213–223. doi: 10.1111/ahg.12203
   PubMed Web of Science ®Google Scholar
• Bazrgar M, Karimi M, Peiravian F, et al. Apolipoprotein E gene polymorphism and left ventricular function in Iranian patients with thalassemia major. Haematologica. 2007;92:256–257. doi: 10.3324/haematol.10708
   PubMed Web of Science ®Google Scholar
• Ferrara M, Matarese SM, Francese M, et al. Role of apolipoprotein E (APOE) polymorphism on left cardiac failure in homozygous beta thalassaemic patients. Br J Haematol. 2001;114(4):959–960. doi: 10.1046/j.1365-2141.2001.03006-6.x
   PubMed Web of Science ®Google Scholar